PolyCYPs kits for the synthesis of oxidized metabolites

Product Description

PolyCYPs Metabolite KitsEasy-to-use in-vitro enzyme system for generation of CYP, AO and FMO derived metabolites of drugs, agrochemicals and other small molecules


PolyCYPs+ metabolite kits are used by scientists in pharmaceutical and agrochemical companies to screen for and scale-up human and other mammalian phase I metabolites.

Hypha’s PolyCYPs enzymes are mined from talented biotransforming strains in  our collection, and are capable of oxidising groups in a wide range of substrate compounds, including arylic/benzylic, -CH, -CH2, -CH3, –tert-butyl, and iso-propyl moieties, as well as aromatic systems for phenols and epoxides. De-alkylation of N– and O-alkyl moieties is also observed. 


Individual "hit" enzymes can be resupplied, alternatively Hypha supports scale up production by mg-gram scale synthesis, purification and identification of target metabolites.

Hypha Discovery Ltd

  • GB
  • 2024
    On CPHI since
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Analytical Services
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Laboratory Services
Natural Extracts
Specifications
  • Details
    Scalable recombinant enzyme kit to make CYP and other Phase I metabolites:
    Screening kits and scale up kits of resupplied individual enzymes available for purchase.
  • Selling Points
    Convenience; Green Product; Product Performance; PolyCYPs is used
  • Supplied from
    United Kingdom

Hypha Discovery Ltd

  • GB
  • 2024
    On CPHI since
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Primary activities
Analytical Services
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Laboratory Services
Natural Extracts

More Products from Hypha Discovery Ltd (6)

  • Custom metabolite synthesis

    Product Custom metabolite synthesis

    Scalable synthesis of phase I and phase II metabolites of drugs and agrochemicals using biotransformation and chemical synthesis.
  • Custom natural products

    Product Custom natural products

    Hypha scientists are experts in the discovery, fermentation, purification and structure elucidation of microbial natural products and can support any aspects of projects in these areas.
  • Impurity purification and identification

    Product Impurity purification and identification

    Purification of metabolites and impurities and structural identification by cryoprobe NMR spectroscopy with certificates of analysis.
  • Metabolite synthesis kits

    Product Metabolite synthesis kits

    Scalable recombinant enzyme kit to make CYP and other Phase I metabolites: Screening kits and scale up kits of resupplied individual enzymes available for purchase.
  • Drug substance impurity purification and identification

    Product Drug substance impurity purification and identification

    Hypha are experts in purification and identification of minor (sub mg) drug substance impurities.Cryoprobe NMR is used to elucidate structures, even when <100ug of impurity is available.
    A range of late-stage biocatalysis and chemistry techniques is available to screen for the production of the impur...
  • Tacrolimus M-II metabolite_31-DeOMe

    Product Tacrolimus M-II metabolite_31-DeOMe

    Tacrolimus metabolite standard

Hypha Discovery Ltd resources (3)